http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#Head
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#assertion
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#provenance
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#pubinfo
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#assertion
http://purl.obolibrary.org/obo/DOID_8534
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_8534
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01233
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
http://www.w3.org/2000/01/rdf-schema#label
the use of metoclopramide tablets is recommended for adults only therapy should not exceed 12 weeks in duration symptomatic gastroesophageal reflux metoclopramide tablets are indicated as short term 4 to 12 weeks therapy for adults with symptomatic documented gastroesophageal reflux who fail to respond to conventional therapy the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms if symptoms are confined to particular situations such as following the evening meal use of metoclopramide as single doses prior to the provocative situation should be considered rather than using the drug throughout the day healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12 week trial using doses of 15 mg q i d as there is no documented correlation between symptoms and healing of esophageal lesions patients with documented lesions should be monitored endoscopically diabetic gastroparesis diabetic gastric stasis metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis the usual manifestations of delayed gastric emptying e g nausea vomiting heartburn persistent fullness after meals and anorexia appear to respond to metoclopramide within different time intervals significant relief of nausea occurs early and continues to improve over a three week period relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB01233
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#provenance
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#pubinfo
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig
http://purl.org/nanopub/x/hasSignature
MXH/9BKoDct3ClrvzS230ZBzsVB85LDJ81fqo8Fe3VjAnMQSMKpMKty/quDaJQ4AyaMq/PHGVFywF7qQbPI6sRJx8kkYJnjYoPE9meam3ZObCZyDlj6fHQvXyozueemGbsx/sCabWeg+AOjgSdnOHG24FQ6Mr2j8+9lkQu5q5qc=
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://purl.org/dc/terms/created
2021-06-21T10:07:59.502+02:00
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs